Viz.ai Stock

www.viz.aiHealthcare / Healthcare softwareFounded: 2016Funding to Date: $253.45MM

Viz.ai, founded in 2016, is an AI-driven modern care coordination technology designed to improve how healthcare is delivered. The Viz Platform features advanced deep learning software that analyzes medical imaging, aiming to accelerate a diagnosis, and increase the speed of diffusion of medical innovation.

Register To Buy and Sell Private Company Shares

For more details on private stock price information, financing and valuation for Viz.ai, register or login.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Private Market Pricing DetailsValuation & Financings

Viz.ai Stock Price

Forge Price 1
Price not yet available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Viz.ai Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
04/07/2022 Series D $100MM $xx.xx $1.22B Tiger Global Management, Insight Partners, Scale Venture Partners, Kleiner Perkins, Threshold Ventures, GV, Sozo Ventures, CRV, Susa Ventures
Price per Share
$xx.xx
Shares Outstanding
15,738,607
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Tiger Global Management, Insight Partners, Scale Venture Partners, Kleiner Perkins, Threshold Ventures, GV, Sozo Ventures, CRV, Susa Ventures
03/17/2021 Series C $71MM $xx.xx $643.65MM Scale Venture Partners, Insight Partners, Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors, Susa Ventures
Price per Share
$xx.xx
Shares Outstanding
19,024,647
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Scale Venture Partners, Insight Partners, Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors, Susa Ventures
10/23/2019 Series B-1 $1.03MM $xx.xx $265.94MM Greenoaks, Threshold Ventures, CRV, GV, Kleiner Perkins
Price per Share
$xx.xx
Shares Outstanding
665,089
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Greenoaks, Threshold Ventures, CRV, GV, Kleiner Perkins
10/23/2019 Series B $53.29MM $xx.xx $265.94MM Greenoaks, Threshold Ventures, CRV, GV, Kleiner Perkins
Price per Share
$xx.xx
Shares Outstanding
30,998,527
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Greenoaks, Threshold Ventures, CRV, GV, Kleiner Perkins
07/18/2018 Series A $20.8MM $xx.xx $72.32MM GV, Kleiner Perkins, DHVC
Price per Share
$xx.xx
Shares Outstanding
30,725,140
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
GV, Kleiner Perkins, DHVC
05/24/2017 Series Seed 2 $4.85MM $xx.xx $34.86MM DHVC, Innovation Endeavors, AME Cloud Ventures
Price per Share
$xx.xx
Shares Outstanding
10,537,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
DHVC, Innovation Endeavors, AME Cloud Ventures
05/24/2017 Series Seed $2.49MM $xx.xx $34.86MM DHVC, Innovation Endeavors, AME Cloud Ventures
Price per Share
$xx.xx
Shares Outstanding
12,162,520
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
DHVC, Innovation Endeavors, AME Cloud Ventures

Viz.ai investors also invested in these private companies

Greenoaks Capital Partners
Candian Imperial Bank Of Commerce

Leadership & Board

Leadership

Chris Mansi
Co-Founder, Chief Executive Officer & Board Member
Julie Skaff
Chief Operating Officer
David Golan
Co-Founder, Chief Technology Officer & Board Member
Gad Sakin
Chief Product Officer and General Manager
Kurt Blasena
Chief Revenue Officer
Jayme Strauss
Chief Clinical Officer
David Kizner
Chief Privacy Officer & General Counsel
Jieun Choe
Chief Marketing Officer

Board

Mamoon Hamid
Kleiner Perkins
Kevin Ding
DHVC
Neil Shah
Greenoaks Capital Partners
Nikhil Sachdev
Insight Partners
Rory O'Driscoll
Scale Venture Partners

Viz.ai stock FAQs

plusminus

Can you buy Viz.ai stock?

As Viz.ai is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like Viz.ai, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
plusminus

How to buy Viz.ai stock?

To invest in a private company like Viz.ai through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Viz.ai stock?

Yes, you may sell the Viz.ai stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Viz.ai stock?

If you hold private company shares of Viz.ai – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Viz.ai on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
plusminus

Is Viz.ai a public company?

No, Viz.ai is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Viz.ai’s stock price?

Viz.ai is a privately held company and therefore does not have a public stock price. However, you may access Viz.ai private market stock price with Forge Data.
plusminus

What is Viz.ai’s stock ticker symbol?

Viz.ai does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Viz.ai’s news and media highlights

Viz.ai has received a de novo approval from the U.S. Food and Drug Administration (FDA) for its new artificial intelligence (AI) algorithm designed to identify signs of hypertrophic cardiomyopathy (HCM) in routine electrocardiograms (ECGs).
Viz.ai has presented three new studies demonstrating the real-world impact of its AI-driven stroke technology. The studies highlight the superior performance of the Viz LVO solution in detecting large vessel occlusion on CT angiography for acute stroke, the value of data in visualising disparities in care and redistributing resources to increase access to stroke care in rural areas, and the successful implementation of Viz.ai's AI-powered solutions to assess and treat chronic subdural haematoma patients.
Named a Unicorn sub-community member, Viz.ai will be offering unique insights and solutions to global healthcare-related issues and how to harness the power of artificial intelligence for common good.
CIBC Innovation Banking has provided $40M in growth capital financing to Viz.ai, a San Francisco-based company that uses artificial intelligence to expedite disease detection and improve patient care. The funding will be used to expand Viz.ai's AI-powered care coordination platform and fuel its expansion, including potential acquisitions.
Updated on: Nov 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.